Skip to main content
Clinical Trials/KCT0002686
KCT0002686
Recruiting
未知

Therapeutic Efficacy of Autologous Platelet Concentrate on Macular hole with High myopia, Large Macular Hole or Recurrent Macular Hole ; Randomized clinical trial

ational Evidence-based Healthcare Callaborating Agency0 sites194 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the eye and adnexa
Sponsor
ational Evidence-based Healthcare Callaborating Agency
Enrollment
194
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
ational Evidence-based Healthcare Callaborating Agency

Eligibility Criteria

Inclusion Criteria

  • Patients who were diagnosed as full\-thickness macular hole by optical coherence tomography with visual acuity of affected eye under 20/50 were included. All subject had to meet at least one of the following conditions.
  • 1\) macular hole over 400µmof minimum size
  • 2\) macular hole at high myopic eye (spherical equivalent over \-6\.0 diopters, or axial length over 25\.5 millimeters)
  • 3\) relapsed of recurrent macular hole

Exclusion Criteria

  • Patients with any following condition were excluded.
  • 1\. Pregnancy
  • 2\. History of retinal detachment, or proliferative vitreoretinopathy in affected eye
  • 3\. History of vitreoretinal surgery for the ocular disease other than macular hole
  • 4\. Proliferative diabetic retinopathy, vitreous hemorrhage, retinal vascular obstruction, uveitis, trauma, optic nerve atrophy, intraocular tumor, or visually significant corneal opacity in affected eye
  • 5\. Confirmed or suspicious intraocular/periocular infection
  • 6\. Uncontrolled high Intraocular pressure (over 21 mmHg) with maximal tolerant medical treatment, or history of glaucoma surgery
  • 7\. Contraindications for using autologous platelet concentrate (thrombocytopenia,any type of thromboasthenia, positive serology of hepatitis B, C, or human immunodeficiency virus, positive serology of syphilis)
  • 8\. Hemodynamic instability
  • 9\. Septicemia

Outcomes

Primary Outcomes

Not specified

Similar Trials